ATE400293T1 - Signal-1/signal-2-bifunktionelle peptidinhibitoren - Google Patents

Signal-1/signal-2-bifunktionelle peptidinhibitoren

Info

Publication number
ATE400293T1
ATE400293T1 AT01991168T AT01991168T ATE400293T1 AT E400293 T1 ATE400293 T1 AT E400293T1 AT 01991168 T AT01991168 T AT 01991168T AT 01991168 T AT01991168 T AT 01991168T AT E400293 T1 ATE400293 T1 AT E400293T1
Authority
AT
Austria
Prior art keywords
chain
signal
moiety
immune response
type
Prior art date
Application number
AT01991168T
Other languages
German (de)
English (en)
Inventor
Joseph Murray
Teruna Siahaan
Yongbo Hu
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Application granted granted Critical
Publication of ATE400293T1 publication Critical patent/ATE400293T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01991168T 2000-12-18 2001-12-17 Signal-1/signal-2-bifunktionelle peptidinhibitoren ATE400293T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/739,466 US7786257B2 (en) 2000-12-18 2000-12-18 Signal-1/signal-2 bifunctional peptide inhibitors

Publications (1)

Publication Number Publication Date
ATE400293T1 true ATE400293T1 (de) 2008-07-15

Family

ID=24972431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01991168T ATE400293T1 (de) 2000-12-18 2001-12-17 Signal-1/signal-2-bifunktionelle peptidinhibitoren

Country Status (8)

Country Link
US (1) US7786257B2 (https=)
EP (2) EP1404362B1 (https=)
JP (1) JP2004536783A (https=)
AT (1) ATE400293T1 (https=)
AU (1) AU2002230911A1 (https=)
CA (1) CA2432767A1 (https=)
DE (1) DE60134791D1 (https=)
WO (1) WO2002050250A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188218B2 (en) 2006-10-27 2012-05-29 University Of Kansas Bi-functional peptides for multiple sclerosis treatment and diagnosis
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
WO2008067281A1 (en) * 2006-11-30 2008-06-05 Vance Products Incorporated D/B/A Cook Urological Incorporated Removable handle for medical device
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
MX2010001779A (es) * 2007-08-15 2010-07-06 Circassia Ltd Peptidos para vacunas.
AU2008317331B2 (en) * 2007-10-25 2013-08-29 The Scripps Research Institute Antibody-mediated disruption of quorum sensing in bacteria
DE102009040716B4 (de) * 2009-09-10 2011-07-14 Miltenyi Biotec GmbH, 51429 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen
WO2011163572A2 (en) 2010-06-24 2011-12-29 University Of Kansas Bifunctional conjugate compositions and associated methods
EP3498300A1 (en) 2011-07-27 2019-06-19 University of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
US9913823B2 (en) * 2011-10-18 2018-03-13 Amorepacific Corporation SIRT 1 activator including syringaresinol
WO2018215506A1 (en) * 2017-05-23 2018-11-29 Université De Genève Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) * 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
EP0576842B1 (de) * 1992-06-11 2002-10-16 MERCK PATENT GmbH Verfahren und Mittel zum Nachweis von Listerien
US5540926A (en) 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
DE69840326D1 (de) 1997-03-27 2009-01-22 Csl Ltd Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
EP1246643A4 (en) * 1999-10-14 2005-05-11 Jeffery A Ledbetter DNA VACCINES ENCODING ANTIGEN ASSOCIATED WITH CD40-BINDING DOMAIN

Also Published As

Publication number Publication date
EP1932539A3 (en) 2008-10-29
US20050107585A1 (en) 2005-05-19
US7786257B2 (en) 2010-08-31
EP1404362A2 (en) 2004-04-07
DE60134791D1 (de) 2008-08-21
WO2002050250A2 (en) 2002-06-27
CA2432767A1 (en) 2002-06-27
EP1404362B1 (en) 2008-07-09
AU2002230911A1 (en) 2002-07-01
WO2002050250A3 (en) 2004-01-08
EP1932539A2 (en) 2008-06-18
EP1404362A4 (en) 2005-06-01
JP2004536783A (ja) 2004-12-09

Similar Documents

Publication Publication Date Title
ATE400293T1 (de) Signal-1/signal-2-bifunktionelle peptidinhibitoren
SE8703012L (sv) Skyddshandske
DE60009511D1 (de) Nematizide trifluorbutene
DE69937419D1 (de) Neisseria Meningitidis Antigene und Zusammenstellungen
DE60327649D1 (de) Markierte nukleotide
CY1110877T1 (el) Αλλαγη των συγγενειων συνδεσης me fcrn ή των ημιζωων ορου αντισωματων με μεταλλαξιγενεση
ATE127474T1 (de) Neue peptidasen und isomerasen-inhibitoren.
CY1108570T1 (el) Gd3-μιμητικα πεπτιδια
DK1254162T3 (da) Kahalalid F og beslægtede forbindelser
BE905918A (fr) Maillon pour une chaine de recueillement de produits.
ATE67860T1 (de) Geraet zur fliess-injektionsanalyse.
DK524388D0 (da) Forbraending af kul med et fluidiseret forbraendingsleje
DE68927630D1 (de) Analoge von Peptrolsubstraten
EP1293567A4 (en) GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02)
ATE108801T1 (de) Antikoagulierende peptid-alkohole.
ATE165369T1 (de) Antikoagulierende peptide
DE58901329D1 (de) Einrichtung zum fortlaufenden reinigen loesungsmittelhaltiger abluft.
DK431189D0 (da) Peptidaseinhibitorer
BR0110969A (pt) Inibição de pepsina por alginatos
FI895844A0 (fi) Koagulation foerhindrande peptider.
DE50102625D1 (de) Verbindungen zur Bestimmung der Aktivität von Phospholipase A2
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
ATE188483T1 (de) Verzweigte peptide zum nachweis von antikörpern
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
DE59903388D1 (de) Schubrostanordnung für einen Festbrennstoff-Kessel o. dgl.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties